LCM
MGNX icon

Laurion Capital Management’s MacroGenics MGNX Stock Holding History

Laurion Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-88,721
Closed -$2.83M – 858
2021
Q1 		$2.83M Buy
+88,721
New +$2.15M 0.02% 394

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Laurion Capital Management's MGNX Position: Q2 2021 in Review

Laurion Capital Management sold out of MacroGenics (MGNX) in Q2 2021, closing a stake of 88,721 shares — an estimated $2.83M sold.

Laurion Capital Management first reported a position in MGNX in Q1 2021 and held it in 1 quarter. The position peaked at $2.83M in Q1 2021. 149 funds tracked by Wall St. Rank hold MGNX as of Q2 2021.

  • Laurion Capital Management reported no remaining MacroGenics position as of Q2 2021 after selling out during the quarter.
  • Laurion Capital Management sold 88,721 MacroGenics shares in Q2 2021, an estimated $2.83M.
  • Laurion Capital Management first reported a position in MacroGenics in Q1 2021 and held it in 1 quarter.
  • Laurion Capital Management's MacroGenics position peaked at $2.83M in Q1 2021.
  • 149 funds tracked by Wall St. Rank held MacroGenics as of Q2 2021.

Based on Laurion Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.